- Home
- FOUR vs HAE Comparison
FOUR vs HAE Comparison
Compare FOUR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOUR
- HAE
- Stock Information
- Founded
- FOUR 1999
- HAE 1971
- Country
- FOUR United States
- HAE United States
- Employees
- FOUR N/A
- HAE N/A
- Industry
- FOUR Business Services
- HAE Medical/Dental Instruments
- Sector
- FOUR Consumer Discretionary
- HAE Health Care
- Exchange
- FOUR Nasdaq
- HAE Nasdaq
- Market Cap
- FOUR 4.5B
- HAE 3.8B
- IPO Year
- FOUR 2020
- HAE 1991
- Fundamental
- Price
- FOUR $96.97
- HAE $89.23
- Analyst Decision
- FOUR Buy
- HAE Strong Buy
- Analyst Count
- FOUR 19
- HAE 8
- Target Price
- FOUR $99.33
- HAE $107.88
- AVG Volume (30 Days)
- FOUR 1.4M
- HAE 726.9K
- Earning Date
- FOUR 11-12-2024
- HAE 11-07-2024
- Dividend Yield
- FOUR N/A
- HAE N/A
- EPS Growth
- FOUR 10.30
- HAE N/A
- EPS
- FOUR 1.87
- HAE 2.41
- Revenue
- FOUR $3,149,000,000.00
- HAE $1,361,223,000.00
- Revenue This Year
- FOUR $41.18
- HAE $7.71
- Revenue Next Year
- FOUR $30.43
- HAE $4.89
- P/E Ratio
- FOUR $51.78
- HAE $37.02
- Revenue Growth
- FOUR 31.37
- HAE 9.84
- 52 Week Low
- FOUR $55.87
- HAE $70.25
- 52 Week High
- FOUR $106.31
- HAE $97.97
- Technical
- Relative Strength Index (RSI)
- FOUR 54.39
- HAE 67.99
- Support Level
- FOUR $95.80
- HAE $70.25
- Resistance Level
- FOUR $106.31
- HAE $94.99
- Average True Range (ATR)
- FOUR 3.86
- HAE 2.67
- MACD
- FOUR 0.22
- HAE 1.67
- Stochastic Oscillator
- FOUR 48.28
- HAE 76.72
About FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.